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ABSTRACT
Short peripheral catheters (SPCs) are the most frequently used medical devices in
hospital settings. Many hospital policies state that SPCs be replaced at 96 hours which
can be unnecessary and costly. A pre-post quality improvement initiative was
implemented following complications surrounding removal of timed SPC catheters with
those removed by clinical indication using the Visual Infusion Phlebitis (VIP) scale.
Data collected included patient demographics, SPC characteristics, nursing time, and
product usage. SPCs replaced based on clinical indication remained intact longer and had
fewer complications than those in the group with routinely replaced SPCs. Decreasing
SPC replacements by use of clinical indication resulted in cost savings of
$7263.60/unit/month.
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Short peripheral catheter (SPC) use is standard practice in US hospitals in which
90% of all patients have an SPC placed.1 The current health care climate ties patient care
closely with reimbursement and payment for services based on quality measures and
patient experience. Limiting the number of SPC insertions and minimizing scheduled
replacement of SPCs can potentiate higher patient satisfaction scores related to pain as
well as demonstrate a decrease in staff time and equipment dollars.
Average dwell time of SPCs is supported by the Centers for Disease Control and
Prevention’s (CDC’s) recommendation to replace them no more frequently than 72 to 96
hours.2 The base cost of insertion ranges from $28 to $35 without weighing the need for
further equipment or intervention.1 Catheter placement and frequent replacement can be
a painful process for patients. The authors’ hospital replaces SPCs at 96 hours to avoid
potential complications of phlebitis regardless of patency of the device. Factors such as
patient age, number of attempts to place the device, catheter gauge, and anatomical
placement position all play a role in the longevity of an SPC, as well as frequency of use.
However, with consumers demanding accountability related to affordable health care,
every effort should be made to minimize discomfort and reduce costs by avoiding
unnecessary procedures.3,4
Accessing and maintaining an SPC, especially in patients with small or fragile
veins, can be difficult. SPCs that are used continuously have shorter dwell times, as do
those used for antibiotic, emergency, or vasoactive use.5 Patients often endure multiple
failed placement attempts due to poor vasculature, staff inexperience, or disease
process.3,6 This can potentiate SPC destabilization, venous depletion, and patient
dissatisfaction.7 Catheter materials and design have progressed over the last 40 years and
now include biocompatible products comprised of silicone and polyurethane.8,9 These
changes have diminished vascular irritation, and have allowed dwell times to exceed the
standard 96- hour guideline, while significantly decreasing catheter-associated
complications.10
Phlebitis and infiltration are frequent complications in determining the need for a
catheter replacement. Frequent SPC placement attempts and reattempts have shown less
device stability and more chance for development of thrombophlebitis.10,11 The Infusion
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removing catheters only when clinically necessary.1,12 Previous research suggested that
SPCs could be kept in place for 96 to120 hours without increasing infection risk and
reducing the need for routine replacement.13 Additionally, multiple research studies have
found fewer or equal occurrences of phlebitis, infiltration, and extravasation in the SPCs
replaced when clinically indicated than with those removed routinely in more than 4000
patients.3,5,14,15 These findings are associated with savings in time, supplies, and health
care dollars, as well as increased satisfaction by patients and clinicians.
METHODS
Design
The Iowa Model was utilized as the framework to develop this pre-post quality
improvement initiative.16 This pre-post evidenced-based practice (EBP) project compared
complication rates surrounding removal of 96-hour timed SPCs with those removed
according to clinical indicators over a period of 30 days. Preintervention data were
obtained retrospectively.
Setting
A 528-bed, tertiary hospital’s medical intensive care unit (MICU), housing 16
critical care beds, a progressive pulmonary care unit housing 8 medical step-down beds,
and 18 medical-surgical beds with a pulmonary focus were utilized. Participants were
chosen via convenience sampling of those admitted to these designated units at the time
of the project.
Ethics
This project was approved through both the academic Institutional Review Board
(IRB) and the Committee on Institutional Cooperation (CIC) of the hospital’s research
and evidence-based practice committee.
Sample
An a priori power analysis was utilized to perform the sample size calculation.17
The criteria for significance was set at a confidence interval of 0.05, utilization of a 2tailed ANOVA test, and power at 80%. A total sample size of 128 SPCs was determined
necessary to yield a significant result in the preintervention group (n = 64) as well as in
the intervention group (n = 64).
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Preintervention Group
The preintervention data were collected retrospectively over 30 days between
August and September 2017. The preintervention group included randomly selected
patients with SPCs chosen by the primary investigator, in the defined investigation areas
before the project began. The preintervention group’s demographic and variable
information was gathered through retrospective chart review via a self-developed data
collection tool. Demographic data included age, sex, ethnicity, and admitting diagnoses.
Variables examined included the registered nurse’s (RN’s) years of work experience,
number of SPC attempts for successful placement, SPC gauge size, anatomic placement
site, days in situ, and reason for SPC removal in relation to a 96-hour timed removal.
Intervention Group Inclusion Criteria
Participants in the intervention group were defined as consenting patients on the
MICU, progressive pulmonary care, and medical-surgical unit during a 30-day project
period occurring from February 1 to March 2, 2018. Men and women over the age of 18
years were included in this project. Participants were defined as English speaking, able to
make independent decisions related to care, and capable of self-consent.
Per hospital policy, the study units’ staff RNs evaluated SPC sites every 8 hours
for signs of phlebitis using the Visual Infusion Phlebitis (VIP) scale.18,19 This scale has
been validated and shown to be reliable in previous research, testing the psychometric
properties of phlebitis assessment scales using the COnsensus-based Standards for the
selection of health Measurement INstruments (COSMIN) guidelines.18,19 The staff RN
documented the VIP scale value under the SPC assessment in the electronic
documentation. VIP scale scores of 0-1 are favorable, meaning the SPC site remains
benign. Catheters that had a score greater or equal to 2 per the VIP scale were removed.
Within the intervention group, if a catheter remained patent at 96 hours (4 days) with a
VIP score less than 2, the RN requested an extension of the dwell time to the provider
team to be removed based on VIP scale. Data were kept confidential during the collection
process on a designated flash drive located in a locked office offsite and were reviewed
on a password-protected computer. Patient medical record numbers were used to identify
patients but were removed for anonymity for dissemination purposes.
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Exclusion Criteria
Patients consent was obtained upon arrival to the investigation unit. Patients with
length of stay (LOS) of 4 days or less were removed from this pilot. Any patient who was
unable to self-consent (eg, related to sedative medication or cognitive disorder) was also
disqualified from participation. Patients who required central vascular access and no
longer needed an SPC were omitted from the study. Patients with SPCs placed by
emergency medical services or outside of the hospital were also excluded, since hospital
policy requires SPC removal within 24 hours of placement. Patients who moved off the
study floor with an SPC in situ for more than 4 days had it removed and replaced when
necessary, to comply with current hospital 96-hour dwell time. Those SPCs were
removed from the data collection.
Consent Process
Participation was voluntary and the primary investigator, who was not a member
of the health care team assigned to the 2 units, obtained consent. A secondary unit-based
clinical nurse specialist (CNS) was used as a consenting resource to provide
information/education and allow open communication with participants regarding the
project, thereby, removing potential for care bias. The teach back method was used to
confirm participant understanding of the project before consent was signed. Patients were
initially evaluated on arrival to the study floor, reevaluated daily for their ability to
consent, and were then approached to participate when appropriate. Family members or a
health care proxy were not utilized in the consent process. Paper consent was scanned
into the participant’s electronic health record.
Preeducation
The investigator met with the participating unit leadership and RN teams to
introduce the project. The investigator reviewed the consent process for those meeting
inclusion criteria, the new process of SPC assessment, the documentation of that
assessment in the electronic health record, and the request for extended SPC dwell time
when an SPC met EBP criteria. A laminated VIP scale poster was placed in each room
and on each workstation on wheels (WOW) for staff/participant reference for the duration
of the project.
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DATA COLLECTION
All preintervention patient demographic and variable information was gathered
using a researcher-developed data collection tool. Data collection occurred over 30 days
between the months of August and September 2017 via retrospective chart review.
Demographic data included age, sex, ethnicity, and admitting diagnoses. Catheter
characteristics examined included number of SPC attempts for successful placement,
SPC gauge size, anatomic placement site, days in situ, and reason for SPC removal. The
RN’s years of work experience was also noted in relation to the number of attempts
before a successful insertion. The intervention group was evaluated utilizing the same
tools in real-time during a 30-day period between February and March 2018.
STATISTICAL ANALYSIS
Analysis of demographic and clinical characteristics were summarized using
descriptive statistics. The pre- and intervention groups were compared using the chisquared tests for nominal data if assumptions of normality were met. The Mann-Whitney
U test was used to compare outcome data when those assumptions were not met.
RESULTS
Sixty-four preintervention SPCs were followed. The intervention sampling frame
included 217 SPCs. Of those, 115 SPCs were excluded related to exclusion criteria, 6
patients refused to participate (accounting for 9 SPCs), and 28 were lost to attrition
leaving 65 SPCs in the sample population (Figure 1). The mean age of the sample was 66
years with a range of 27 to 93 years. The distribution of gender was significantly different
from preintervention compared to postintervention. A chi square analysis revealed that
there were more females in the pre-intervention group (n = 42, 62.7%; χ2(1) = 4.7, P =
.03). As shown in Table 1, there was no difference across pre- and postintervention
groups related to age or race. On average, across both samples 20-gauge catheters (n =
40, 59.7%; χ2 (131) = -0.373, P = .71) were predominantly placed in the patient’s forearm
(n = 29, 43.9%; t(125.079) = -5.12, P = .022) with 1 attempt (n = 44, 65.7%) (Table 2).
Though gauge size and number of attempts weren’t significant, placement in the forearm
showed greater SPC stability and therefore potentiated longer days in situ.

As shown in Table 2, the intervention group had longer days in situ. A Mann-
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Whitney U test revealed that the intervention group had significantly longer days in situ
(n = 31, 46.9%; U = 951.5, P = .001) and remained in situ less than 120 hours (5 days) in
comparison to the pregroup in situ time of 54 hours (2.4 days). There were fewer
infiltrations (n = 6, 9.1%) and no complications of phlebitis among the intervention
group. Among both groups, “per protocol” (n = 9,13.4%; n = 29, 43.9%); was the most
common reason for SPC removal.

DISCUSSION
The purpose of this investigation was to determine if replacing SPCs by clinical
indication would be a safe alternative to current facility practice (routine replacement
based on 96-hour dwell time) and appraise any fiscal implications. During this project,
SPCs consistently remained intact without complications of phlebitis or infection. These
findings are consistent with what has been written in the literature—phlebitis and
infiltration are the most common risks of extended dwell times.8 There was no evidence
of phlebitis in the intervention group, and infiltration was accountable for only a few
SPC removals.
It was interesting to note, on average, the SPCs in the intervention group, though
anticipated to remain a minimum of 5 or more days, lasted only 4.5 days. The mean in
situ time of the preintervention group was less than 2 days. This can be associated with a
number of factors: 1) this study was conducted primarily in a critical care setting and an
acute medical-surgical floor during the winter months; 2) the most common patient
diagnosis across the study was respiratory disorders, kidney disease, and cancer; and 3)
higher patient acuity, vascular frailty, and frequency and type of intravenous (IV)
medications may have played a role in a more accelerated SPC mortality in both groups.
Previous research has also investigated many aspects associated with catheter
failure rates, including the experience and skill of clinicians placing and maintaining the
devices.6,8,13 There were many novice nurses practicing in these study units, and although
a self-assessment of their individual skills was not examined in this study, it should be
considered in future investigations.

Equipment cost for this health system was $3.50 per IV-start package including 1
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SPC catheter, a 10-mL pre-filled normal saline flush, 1 alcohol pad, tourniquet, 1 sterile
2×2 gauze, 1 windowed dressing, and 1 extension set. RN time was evaluated based on
experience level and average pay rate of a new graduate/novice nurse (≤ 2.9 years of
experience) and experienced RN (≥ 3 years’ experience). The average base pay of an
experienced RN at this facility was $31.75/hour. It was deemed to take 5 to 7 minutes
($3.70) to place an SPC with an average of ≤ 1 to 2 attempts ($7.20/attempt). The
average base pay of a new graduate RN at this facility was $26.00/hour. Placement was
deemed to take 10 to 15 minutes ($6.50/attempt) with an average of 2 attempts
($10/attempt). Patient LOS on the study units was 6 to 8 days. Since there was no need
to replace some SPCs at day 4, many stayed in situ until discharge.
Through the project duration, unit SPC equipment need and staff time decreased
by 40%, resulting in a unit equipment savings of $52.50/unit/month and
$552.80/unit/month in nursing time saving. With 28 inpatient units within the facility,
the yearly-extrapolated hospital savings for introducing this initiative would yield
$7,263.60/unit/year or $203,380.80 in annual savings.

LIMITATIONS
Limitations of this study included a small convenience sample size within a single
center. Surgical patients were not included, so conclusions cannot be inferred across the
adult hospital population. A new brand of SPC was introduced to the facility during the
preintervention group in August 2017 that may have accounted for the lower mean days
in situ and frequency of failed attempts.

CONCLUSION
Although patient satisfaction was not evaluated in this study, considerable health
care dollars are tied to that metric. Through the Hospital Consumer Assessment of
Healthcare Providers and Systems survey, patients rate their inpatient stay on many care
aspects from pain management to quietness. Low scores can mean loss of reimbursement
dollars as high as 2%, noted during the 2017 fiscal year.20 Limiting patient venipunctures

while allowing longer dwell times can both increase nurse and patient satisfaction and

9

limit replacement time and waste.
Studies have concluded that better education, annual competence, and mentorship
of novice nurses improved skill prowess resulting in fewer instances of SPC-associated
complications and catheter failure.11,21,22,23 There is agreement among the research that
utilizing an objective SPC assessment tool, rather than clinical judgment, aids in the
appropriate timing of SPC removal that is supported by this study.15,17
The inability to obtain and maintain vascular access has significant negative
consequences, including delay in treatment, complications leading to prolonged LOS,
and costly subsequent medical intervention; whereas maintenance of vascular access can
lead to increased nurse time to focus on more acute issues and, most important,
improving the patient outcome and experience. 22 Recent studies have evaluated the
current placement and maintenance guidelines with regard to prolonging dwell time of
an SPC, removing them only when clinically necessary.1,3,14,15 The findings presented in
this article are encouraging, indicating that with careful observation, SPCs can dwell
longer than the current CDC recommendation of replacement no more frequently than
72 to 96 hours.
Further research is needed on nursing responsibilities in SPC placement and
maintenance practices. The goal of this research builds towards strengthening nursing
practice to include a nurse-driven, evidence-based placement and removal protocol that
is patient focused. The hope is that this will continue to bolster patient care, staff and
patient satisfaction, and fiscally responsibility.
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Figure 1 Sample distribution of the intervention group
Abbreviations: 5400, medical-surgical unit; MAT, medical assessment and treatment
(progressive care unit); MICU, medical intensive care unit.
Table 1. Demographic Description of Study Sample

Table 2. Catheter Characteristics (N=132)
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Potential Patients: N= 217
MICU= 101
MAT=47
5400= 69
Consentable: n= 102

Excluded: n= 115

MICU= 49

MICU= 57

MAT=17

MAT=20

5400= 36

5400= 38

Refused: n= 9

Attrition: n= 27

MICU= 2

MICU= 7

MAT=2

MAT= 10

5400= 5

5400= 9
Study patients: n= 66
MICU= 40
MAT= 5
5400= 20

Figure 1 Sample distribution of the intervention group. Abbreviations: 5400, medical-surgical unit;
MAT, medical assessment and treatment (progressive care unit); MICU, medical intensive care unit.

Table 1. Demographic Description of Study Sample

Patient Demographics
(N=132)

Age in Years (m,sd)
Race
African American
Caucasian
Hispanic
Gender
Male
Female
Diagnosis
AKI/ESRD/dehydration
Anemia
Respiratory failure
Cancer
CAD
CHF
Cholangitis
COPD
DKA
Pneumonia
Pulmonary embolus
Pulmonary hypertension
Pylonephritis
SIRS/sepsis/shock
GI disorders

Preintervention
n= 67

Intervention
n= 66

n (%)

n (%)

67 (13.67)

66 (14.25)

13 (19.4)
54 (80.6)
0 (0.0)

16 (24.2)
46 (69.7)
4 (6.1)

25 (37.3)
42 (62.7)

37 (56.1)
29 (43.9)

4 (6.0)
NA
22 (35.9)
11 (16.5)
NA
6 (9.0)
NA
1 (1.5)
NA
3 (4.5)
NA
NA
NA
10(13.5)
10 (13.5)

13 (19.7)
5 (7.6)
14 (19.7)
2 (3.0)
2 (3.0)
1 (1.5)
2 (3.0)
2 (3.0)
1 (1.5)
NA
2 (3.0)
2 (3.0)
4 (6.1)
9 (13.6)
7 (10.6)

P Value

0.94
0.08

0.03
0.001

Abbreviations: Acute Kidney Injury (AKI); Coronary Artery Disease (CAD); Congestive Heart Failure (CHF);
Chronic Obstructive Pulmonary Disease COPD; Diabetic Ketoacidosis (DKA); End-Stage Renal
Disease(ESRD); Gastrointestinal (GI); Systemic Inflammatory Response Syndrome (SIRS);

________________________________________________________________________________
Table 2. Catheter Characteristics (N=132)
Variable

Number of Attempts
1
2
3
Not documented
Placement Site
Left Antecubital
Left forearm
Left hand
L eft wrist
Not documented
Right Antecubital
Right forearm
Right hand
Right wrist
SPC Gauge Size
(m,sd)
16
18
20
22
*Days in Situa
(m,sd)
0-4
5
6
7
8-10
Reason For Removal
Catheter damage
Replaced by central access
Discharge home
Drainage/leaking
Infiltration
Not documented
Occlusion
Per family request
Per hospital protocol
Phlebitis
Removed by patient
a

Mann-Whitney U test performed.

Pre-intervention
n= 67

Post-intervention
n= 66

n (%)

n (%)

44 (65.7)
6 (9.0)
3 (4.5)
14 (20.9)

47 (71.2)
5 (7.6)
1 (1.5)
13 (19.7)

13 (21.5)
9 (13.4)
10 (10.5)
2 (3.0)
1 (1.5)
6 (9.0)
13 (21.7)
4 (6.0)
9 (13.4)
20 (1.32)
1 (1.5)
16 (23.9)
40 (59.7)
10 (14.9)
2.54 (1.7)
61 (91.1)
4 (6)
1 (1.5)
1 (1.5)
NA
4 (6.0)
1 (1.5)
NA
1 (1.5)
12 (17.9)
10 (14.9)
4 (6.0)
2 (3.0)
23 (34.3)
1 (1.5)
9 (13.4)

9 (13.6)
16 (24.2)
4 (6.1)
5 (7.6)
NA
12 (18.2)
13 (19.7)
3 (4.5)
4 (6.1)
20 (1.37)
1 (1.5)
15 (22.7)
38 (57.6)
12 (18.2)
4.59 (2.4)
35 (53.1)
8 (12.1)
2 (3.0)
13 (19.7)
8 (12.1)
4 (6.1)
1 (1.5)
9 (13.6)
4 (6.1)
6 (9.1)
6 (9.1)
5 (7.6)
1 (1.5)
29 (43.9)
NA
1 (1.5)

P Value

0.45

0.02

0.71

0.001

0.001

